This Week in Cell

The Massachusetts Institute of Technology's Rudolf Jaenisch and colleagues report on a genome editing approach that takes advantage of a type II bacterial CRISPR/CAS system. By directing messenger RNA from the Cas9 gene to genomic sequences of interest with the help of single-guided RNAs, the researchers demonstrated that they could generate mice carrying fluorescent tags or conditional mutations at several genes in a single step.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.